Evidence map›Paper›PMID 27302973›Full record

ArticleJournal of Crohn's & colitis2017

Phenotypic and Genotypic Characterisation of Inflammatory Bowel Disease Presenting Before the Age of 2 years.

Jochen Kammermeier, Robert Dziubak, Matilde Pescarin, Suzanne Drury, Heather Godwin, Kate Reeve, Sibongile Chadokufa, Bonita Huggett, Sara Sider, Chela James and 12 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Journal of Crohn's & colitis, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06986382 (Phase 1b/2a Trial of Allogeneic Hematopoietic Stem Cell Transplantation), which is not on this map. Cited by 69 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 2 pooled it
16.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06986382 phase1 / phase2not yet recruitingnot on this mapstarted 2025, after this paper: background citation

Phase 1b/2a Trial of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) From an HLA-partially Matched Related or Unrelated Donor After TCRab+ T-cell/CD19+ B-cell Depletion for Patients With Monogenic and/or Early-onset (EO), Medically Refractory (MR) Crohn Disease (CD)

TypeinterventionalSponsorStanford UniversityRan2025 to 2040Enrolled14ConditionsCrohn DiseaseArmsCliniMACS® TCR α/β Reagent Kit and CliniMACS® CD19 System, Prednisone/Methylprenisolone, Palifermin, ATG, Clofarabine
3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 2 syntheses or guidelines pooled it, 171 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Monogenic inflammatory bowel disease: An unfolding enigma.World journal of clinical pediatrics · 2025
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 4 institutions in 1 country.

Jochen KammermeierGenetics and Genomic Medicine, Institute of Child Health, University College London, London, UK j.kammermeier@ucl.ac.uk.
Robert DziubakDepartment of Gastroenterology, Great Ormond Street Hospital, London, UK.
Matilde PescarinDepartment of Gastroenterology, Great Ormond Street Hospital, London, UK.
Suzanne DruryGenetics and Genomic Medicine, Institute of Child Health, University College London, London, UK.
Heather GodwinDepartment of Gastroenterology, Great Ormond Street Hospital, London, UK.
Kate ReeveDepartment of Gastroenterology, Great Ormond Street Hospital, London, UK.
Sibongile ChadokufaDepartment of Gastroenterology, Great Ormond Street Hospital, London, UK.
Bonita HuggettDepartment of Gastroenterology, Great Ormond Street Hospital, London, UK.
Sara SiderDepartment of Gastroenterology, Great Ormond Street Hospital, London, UK.
Chela JamesGenetics and Genomic Medicine, Institute of Child Health, University College London, London, UK.
Nikki ActonDepartment of Gastroenterology, Great Ormond Street Hospital, London, UK.
Elena CernatDepartment of Gastroenterology, Great Ormond Street Hospital, London, UK.
Marco GasparettoDepartment of Paediatric Gastroenterology, Addenbrookes Hospital, Cambridge, UK.
Gabi Noble-JamiesonDepartment of Paediatric Gastroenterology, Addenbrookes Hospital, Cambridge, UK.
Fevronia KiparissiDepartment of Gastroenterology, Great Ormond Street Hospital, London, UK.
Mamoun ElawadDepartment of Gastroenterology, Great Ormond Street Hospital, London, UK.
Phil L BealesGenetics and Genomic Medicine, Institute of Child Health, University College London, London, UK.
Neil J SebireDepartment of Histopathology, Great Ormond Street Hospital, London, UK.
Kimberly GilmourDepartment of Immunology, Great Ormond Street Hospital, London, UK.
Holm H UhligTransitional Gastroenterology Unit, Nuffield Department of Medicine and Department of Paediatrics, University of Oxford, UK.
Chiara BacchelliGenetics and Genomic Medicine, Institute of Child Health, University College London, London, UK.
Neil ShahDepartment of Gastroenterology, Great Ormond Street Hospital, London, UK.
Great Ormond Street Hospital · GBUniversity College London · GBAddenbrooke's Hospital · GBUniversity of Oxford · GB

Funding

Medical Research Council G0801843
6 · The paper itself

Abstract

objectivesInflammatory bowel disease [IBD] presenting in early childhood is extremely rare. More recently, progress has been made to identify children with monogenic forms of IBD predominantly presenting very early in life. In this study, we describe the heterogeneous phenotypes and genotypes of patients with IBD presenting before the age of 2 years and establish phenotypic features associated with underlying monogenicity.

methodsPhenotype data of 62 children with disease onset before the age of 2 years presenting over the past 20 years were reviewed. Children without previously established genetic diagnosis were prospectively recruited for next-generation sequencing.

resultsIn all, 62 patients [55% male] were identified. The median disease onset was 3 months of age (interquartile range [IQR]: 1 to 11). Conventional IBD classification only applied to 15 patients with Crohn's disease [CD]-like [24%] and three with ulcerative colitis [UC]-like [5%] phenotype; 44 patients [71%] were diagnosed with otherwise unclassifiable IBD. Patients frequently required parenteral nutrition [40%], extensive immunosuppression [31%], haematopoietic stem-cell transplantation [29%], and abdominal surgery [19%]. In 31% of patients, underlying monogenic diseases were established [EPCAM, IL10, IL10RA, IL10RB, FOXP3, LRBA, SKIV2L, TTC37, TTC7A]. Phenotypic features significantly more prevalent in monogenic IBD were: consanguinity, disease onset before the 6th month of life, stunting, extensive intestinal disease and histological evidence of epithelial abnormalities.

conclusionsIBD in children with disease onset before the age of 2 years is frequently unclassifiable into Crohn's disease and ulcerative colitis, particularly treatment resistant, and can be indistinguishable from monogenic diseases with IBD-like phenotype.

Indexed as

Age of OnsetColitis, UlcerativeCrohn DiseaseEndoscopy, GastrointestinalFemaleGenetic TestingHumansInfantInflammatory Bowel DiseasesIntestinesMalePhenotypegeneticsimmunodeficiencyinfantile-onsetInflammatory bowel diseasenext-generation sequencingpaediatricsphenotype

Identifiers

PMID27302973
PMCPMC5885808
OpenAlexW2441166434

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.